Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Pensions
Having Neuroendocrine Cancer diagnosis can have an effect on all aspects of your life, from your ability to work/study to financial matters to getting insurance to travel. This Wednesday, September 15th, is Pension Awareness Day. A question many people ask after a...
Cancer and COVID-19 vaccination : 3rd dose and booster explained.
Third dose of vaccine being offered to those who were severely immunocompromised at the time of their first or second COVID vaccination dose. In brief : Third dose - is a 3rd COVID vaccination, given no sooner than 8 weeks after the 2nd COVID vaccination, for those...
COVID and Cancer – Antibody survey launching 20th September
Antibodies are a type of immune cell and while testing antibody levels can help assess an individual’s response to vaccination (or prior infection) - it may not give all of the information that may be available about that person’s immune response. An antibody, is a...